Literature DB >> 26504756

Formation and Characterization of Beclomethasone Dipropionate Nanoparticles Using Rapid Expansion of Supercritical Solution.

Mohsen Hosseinpour1, Alireza Vatanara2, Reza Zarghami1.   

Abstract

PURPOSE: Particle size of Beclometasone Dipropionate (BDP) was reduced by the rapid expansion of supercritical solution (RESS) process, using CO2 as supercritical solvent. Also, the effect of RESS parameters such as extraction pressure, pre-expansion temperature, and weight fraction of co-solvent on the size and distribution of BDP particles were investigated.
METHODS: The effects of extraction pressure (200-260 bar), pre-expansion temperature (70-110 °C) and weight fraction of menthol as a co-solvent on mean particle size (MPS) of BDP were investigated by design of experiment (DOE). Particles were characterized using Scanning Electron Microscopy (SEM) and Dynamic Light Scattering (DLS).
RESULTS: The average sizes of precipitated BDP were between 64.1 and 294 nm. Analysis of variance (ANOVA) showed that extraction pressure was the most significant parameter and a higher extraction pressure caused production of smaller particles. Also, it was found that higher temperature and weight fraction of co-solvent increased the MPS. The interaction effects of extraction pressure-pre-expansion temperature and pre-expansion temperature-co-solvent ratio were significant through the analysis of variance. It was observed that the MPS of precipitated particles was mostly influenced by pressure.
CONCLUSION: The smallest MPS of BDP obtained from the RESS process was 65 nm that revealed a significant size reduction from its original MPS of 9 μm. Moreover, a slight change was observed for precipitated particles of BDP into spherical form while the original particles were irregular in shape. RESS process showed as a promising method for production of BDP nanoparticles that may results in improvement of drug's physicochemical properties.

Entities:  

Keywords:  Beclometasone Dipropionate; Nanoparticle; RESS; Supercritical

Year:  2015        PMID: 26504756      PMCID: PMC4616900          DOI: 10.15171/apb.2015.048

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  6 in total

Review 1.  Preparation of drug delivery systems using supercritical fluid technology.

Authors:  U B Kompella; K Koushik
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2001       Impact factor: 4.889

Review 2.  Solid dispersions: revival with greater possibilities and applications in oral drug delivery.

Authors:  Sundeep Sethia; Emilio Squillante
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2003       Impact factor: 4.889

Review 3.  Design and process aspects of laboratory scale SCF particle formation systems.

Authors:  Chandra Vemavarapu; Matthew J Mollan; Mayur Lodaya; Thomas E Needham
Journal:  Int J Pharm       Date:  2005-03-23       Impact factor: 5.875

Review 4.  Micronization processes with supercritical fluids: fundamentals and mechanisms.

Authors:  A Martín; M J Cocero
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 5.  Nanoparticles synthesis using supercritical fluid technology - towards biomedical applications.

Authors:  K Byrappa; S Ohara; T Adschiri
Journal:  Adv Drug Deliv Rev       Date:  2007-10-12       Impact factor: 15.470

6.  The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.

Authors:  C P van Schayck; D Donnell
Journal:  Int J Clin Pract       Date:  2004-08       Impact factor: 2.503

  6 in total
  1 in total

1.  Melting Point Depression of Poly(ethylene oxide)-Poly(propylene oxide)-Poly(ethylene oxide) Triblock Polymers in Supercritical Carbon Dioxide in the Presence of Menthol as a Solid Co-Plasticiser.

Authors:  Vivek Trivedi; Adejumoke Lara Ajiboye; Nichola J Coleman; Ruchir Bhomia; Marion Bascougnano
Journal:  Polymers (Basel)       Date:  2022-07-11       Impact factor: 4.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.